Inozyme Pharma's Series A Round

Inozyme Pharma raised a round of funding on November 15, 2017.

Inozyme Pharma is a biotechnology company committed to developing novel medicines for the treatment of rare diseases characterized by mineral imbalances, which lead to over calcification of soft tissu…

Articles about Inozyme Pharma's Series A Round: